0
     

Report Added
Report already added
Microbiomes Market in India - Industry Outlook and Forecast 2020-2026

Microbiomes Market in India - Industry Outlook and Forecast 2020-2026

This report contains market size and forecasts of Microbiomes in India, including the following market information:_x000D_
India Microbiomes Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
Top Five Competitors in India Microbiomes Market 2019 (%)_x000D_
The global Microbiomes market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Microbiomes market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
Total Market by Segment:_x000D_
India Microbiomes Market, By Type, 2015-2020, 2021-2026 ($ millions)_x000D_
India Microbiomes Market Segment Percentages, By Type, 2019 (%)_x000D_
Gastrointestinal Microbiome_x000D_
Genitourinary Microbiome_x000D_
Skin Microbiome_x000D_
Respiratory Microbiome_x000D_
Other_x000D_
_x000D_
India Microbiomes Market, By Application, 2015-2020, 2021-2026 ($ millions)_x000D_
India Microbiomes Market Segment Percentages, By Application, 2019 (%)_x000D_
Testing_x000D_
Treatment_x000D_
Diagnosis_x000D_
Technology Platform_x000D_
Probiotics_x000D_
Other_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Microbiomes Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Microbiomes Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
4D Pharma_x000D_
Enterome BioScience_x000D_
Evelo Biosciences_x000D_
Ferring_x000D_
Osel_x000D_
Second Genome_x000D_
Seres Therapeutics_x000D_
Synlogic_x000D_
Synthetic Biologics and Vedanta Biosciences_x000D_
Vedanta_x000D_
Rebiotix_x000D_
ActoGeniX_x000D_
Enterologics_x000D_
Metabogen_x000D_
Metabiomics_x000D_
Ritter Pharmaceuticals_x000D_
AvidBiotics_x000D_
Symberix_x000D_
Miomics_x000D_
Symbiotix Biotherapies_x000D_
MicroBiome Therapeutics LLC_x000D_
SciBac Inc_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Microbiomes Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Market by Type_x000D_
1.2.2 Market by Application_x000D_
1.3 India Microbiomes Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 India Microbiomes Overall Market Size_x000D_
2.1 India Microbiomes Market Size: 2020 VS 2026_x000D_
2.2 India Microbiomes Revenue, Prospects & Forecasts: 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Microbiomes Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Microbiomes Companies Ranked by Revenue_x000D_
3.3 India Microbiomes Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 Top 3 and Top 5 Microbiomes Companies in India, by Revenue in 2019_x000D_
3.5 India Manufacturers Microbiomes Product Type_x000D_
3.6 Tier 1, Tier 2 and Tier 3 Microbiomes Players in India_x000D_
3.6.1 List of India Tier 1 Microbiomes Companies_x000D_
3.6.2 List of India Tier 2 and Tier 3 Microbiomes Companies_x000D_
_x000D_
4 Market Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Microbiomes Market Size Markets, 2020 & 2026_x000D_
4.1.2 Gastrointestinal Microbiome_x000D_
4.1.3 Genitourinary Microbiome_x000D_
4.1.4 Skin Microbiome_x000D_
4.1.5 Respiratory Microbiome_x000D_
4.1.6 Other_x000D_
4.2 By Type - India Microbiomes Revenue & Forecasts_x000D_
4.2.1 By Type - India Microbiomes Revenue, 2015-2020_x000D_
4.2.2 By Type - India Microbiomes Revenue, 2021-2026_x000D_
4.2.3 By Type - India Microbiomes Revenue Market Share, 2015-2026_x000D_
5 Market Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Microbiomes Market Size, 2020 & 2026_x000D_
5.1.2 Testing_x000D_
5.1.3 Treatment_x000D_
5.1.4 Diagnosis_x000D_
5.1.5 Technology Platform_x000D_
5.1.6 Probiotics_x000D_
5.1.7 Other_x000D_
5.2 By Application - India Microbiomes Revenue & Forecasts_x000D_
5.2.1 By Application - India Microbiomes Revenue, 2015-2020_x000D_
5.2.2 By Application - India Microbiomes Revenue, 2021-2026_x000D_
5.2.3 By Application - India Microbiomes Revenue Market Share, 2015-2026_x000D_
6 Players Profiles_x000D_
6.1 4D Pharma_x000D_
6.1.1 4D Pharma Corporate Summary_x000D_
6.1.2 4D Pharma Business Overview_x000D_
6.1.3 4D Pharma Microbiomes Major Product Offerings_x000D_
6.1.4 4D Pharma Revenue in India (2015-2020)_x000D_
6.1.5 4D Pharma Key News_x000D_
6.2 Enterome BioScience_x000D_
6.2.1 Enterome BioScience Corporate Summary_x000D_
6.2.2 Enterome BioScience Business Overview_x000D_
6.2.3 Enterome BioScience Microbiomes Major Product Offerings_x000D_
6.2.4 Enterome BioScience Revenue in India (2015-2020)_x000D_
6.2.5 Enterome BioScience Key News_x000D_
6.3 Evelo Biosciences_x000D_
6.3.1 Evelo Biosciences Corporate Summary_x000D_
6.3.2 Evelo Biosciences Business Overview_x000D_
6.3.3 Evelo Biosciences Microbiomes Major Product Offerings_x000D_
6.3.4 Evelo Biosciences Revenue in India (2015-2020)_x000D_
6.3.5 Evelo Biosciences Key News_x000D_
6.4 Ferring_x000D_
6.4.1 Ferring Corporate Summary_x000D_
6.4.2 Ferring Business Overview_x000D_
6.4.3 Ferring Microbiomes Major Product Offerings_x000D_
6.4.4 Ferring Revenue in India (2015-2020)_x000D_
6.4.5 Ferring Key News_x000D_
6.5 Osel_x000D_
6.5.1 Osel Corporate Summary_x000D_
6.5.2 Osel Business Overview_x000D_
6.5.3 Osel Microbiomes Major Product Offerings_x000D_
6.5.4 Osel Revenue in India (2015-2020)_x000D_
6.5.5 Osel Key News_x000D_
6.6 Second Genome_x000D_
6.6.1 Second Genome Corporate Summary_x000D_
6.6.2 Second Genome Business Overview_x000D_
6.6.3 Second Genome Microbiomes Major Product Offerings_x000D_
6.6.4 Second Genome Revenue in India (2015-2020)_x000D_
6.6.5 Second Genome Key News_x000D_
6.7 Seres Therapeutics_x000D_
6.6.1 Seres Therapeutics Corporate Summary_x000D_
6.6.2 Seres Therapeutics Business Overview_x000D_
6.6.3 Seres Therapeutics Microbiomes Major Product Offerings_x000D_
6.4.4 Seres Therapeutics Revenue in India (2015-2020)_x000D_
6.7.5 Seres Therapeutics Key News_x000D_
6.8 Synlogic_x000D_
6.8.1 Synlogic Corporate Summary_x000D_
6.8.2 Synlogic Business Overview_x000D_
6.8.3 Synlogic Microbiomes Major Product Offerings_x000D_
6.8.4 Synlogic Revenue in India (2015-2020)_x000D_
6.8.5 Synlogic Key News_x000D_
6.9 Synthetic Biologics and Vedanta Biosciences_x000D_
6.9.1 Synthetic Biologics and Vedanta Biosciences Corporate Summary_x000D_
6.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview_x000D_
6.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Major Product Offerings_x000D_
6.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in India (2015-2020)_x000D_
6.9.5 Synthetic Biologics and Vedanta Biosciences Key News_x000D_
6.10 Vedanta_x000D_
6.10.1 Vedanta Corporate Summary_x000D_
6.10.2 Vedanta Business Overview_x000D_
6.10.3 Vedanta Microbiomes Major Product Offerings_x000D_
6.10.4 Vedanta Revenue in India (2015-2020)_x000D_
6.10.5 Vedanta Key News_x000D_
6.11 Rebiotix_x000D_
6.11.1 Rebiotix Corporate Summary_x000D_
6.11.2 Rebiotix Microbiomes Business Overview_x000D_
6.11.3 Rebiotix Microbiomes Major Product Offerings_x000D_
6.11.4 Rebiotix Revenue in India (2015-2020)_x000D_
6.11.5 Rebiotix Key News_x000D_
6.12 ActoGeniX_x000D_
6.12.1 ActoGeniX Corporate Summary_x000D_
6.12.2 ActoGeniX Microbiomes Business Overview_x000D_
6.12.3 ActoGeniX Microbiomes Major Product Offerings_x000D_
6.12.4 ActoGeniX Revenue in India (2015-2020)_x000D_
6.12.5 ActoGeniX Key News_x000D_
6.13 Enterologics_x000D_
6.13.1 Enterologics Corporate Summary_x000D_
6.13.2 Enterologics Microbiomes Business Overview_x000D_
6.13.3 Enterologics Microbiomes Major Product Offerings_x000D_
6.13.4 Enterologics Revenue in India (2015-2020)_x000D_
6.13.5 Enterologics Key News_x000D_
6.14 Metabogen_x000D_
6.14.1 Metabogen Corporate Summary_x000D_
6.14.2 Metabogen Microbiomes Business Overview_x000D_
6.14.3 Metabogen Microbiomes Major Product Offerings_x000D_
6.14.4 Metabogen Revenue in India (2015-2020)_x000D_
6.14.5 Metabogen Key News_x000D_
6.15 Metabiomics_x000D_
6.15.1 Metabiomics Corporate Summary_x000D_
6.15.2 Metabiomics Microbiomes Business Overview_x000D_
6.15.3 Metabiomics Microbiomes Major Product Offerings_x000D_
6.15.4 Metabiomics Revenue in India (2015-2020)_x000D_
6.15.5 Metabiomics Key News_x000D_
6.16 Ritter Pharmaceuticals_x000D_
6.16.1 Ritter Pharmaceuticals Corporate Summary_x000D_
6.16.2 Ritter Pharmaceuticals Microbiomes Business Overview_x000D_
6.16.3 Ritter Pharmaceuticals Microbiomes Major Product Offerings_x000D_
6.16.4 Ritter Pharmaceuticals Revenue in India (2015-2020)_x000D_
6.16.5 Ritter Pharmaceuticals Key News_x000D_
6.17 AvidBiotics_x000D_
6.17.1 AvidBiotics Corporate Summary_x000D_
6.17.2 AvidBiotics Microbiomes Business Overview_x000D_
6.17.3 AvidBiotics Microbiomes Major Product Offerings_x000D_
6.17.4 AvidBiotics Revenue in India (2015-2020)_x000D_
6.17.5 AvidBiotics Key News_x000D_
6.18 Symberix_x000D_
6.18.1 Symberix Corporate Summary_x000D_
6.18.2 Symberix Microbiomes Business Overview_x000D_
6.18.3 Symberix Microbiomes Major Product Offerings_x000D_
6.18.4 Symberix Revenue in India (2015-2020)_x000D_
6.18.5 Symberix Key News_x000D_
6.19 Miomics_x000D_
6.19.1 Miomics Corporate Summary_x000D_
6.19.2 Miomics Microbiomes Business Overview_x000D_
6.19.3 Miomics Microbiomes Major Product Offerings_x000D_
6.19.4 Miomics Revenue in India (2015-2020)_x000D_
6.19.5 Miomics Key News_x000D_
6.20 Symbiotix Biotherapies_x000D_
6.20.1 Symbiotix Biotherapies Corporate Summary_x000D_
6.20.2 Symbiotix Biotherapies Microbiomes Business Overview_x000D_
6.20.3 Symbiotix Biotherapies Microbiomes Major Product Offerings_x000D_
6.20.4 Symbiotix Biotherapies Revenue in India (2015-2020)_x000D_
6.20.5 Symbiotix Biotherapies Key News_x000D_
6.21 MicroBiome Therapeutics LLC_x000D_
6.21.1 MicroBiome Therapeutics LLC Corporate Summary_x000D_
6.21.2 MicroBiome Therapeutics LLC Microbiomes Business Overview_x000D_
6.21.3 MicroBiome Therapeutics LLC Microbiomes Major Product Offerings_x000D_
6.21.4 MicroBiome Therapeutics LLC Revenue in India (2015-2020)_x000D_
6.21.5 MicroBiome Therapeutics LLC Key News_x000D_
6.22 SciBac Inc_x000D_
6.22.1 SciBac Inc Corporate Summary_x000D_
6.22.2 SciBac Inc Microbiomes Business Overview_x000D_
6.22.3 SciBac Inc Microbiomes Major Product Offerings_x000D_
6.22.4 SciBac Inc Revenue in India (2015-2020)_x000D_
6.22.5 SciBac Inc Key News_x000D_
_x000D_
7 Key Market Trends & Influences 2021-2026_x000D_
7.1 PESTLE Analysis for India Microbiomes Market_x000D_
7.2 Market Opportunities & Trends_x000D_
7.3 Market Drivers_x000D_
7.4 Market Restraints_x000D_
_x000D_
8 Conclusion_x000D_
_x000D_
9 Appendix_x000D_
9.1 Note_x000D_
9.2 Examples of Clients_x000D_
9.3 Disclaimer_x000D_List of Tables_x000D_
Table 1. Key Players of Microbiomes in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Microbiomes Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Microbiomes Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Microbiomes Sales by Companies, (K Units), 2015-2020_x000D_
Table 6. India Microbiomes Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Microbiomes Price (2015-2020) (US$/Unit)_x000D_
Table 8. India Manufacturers Microbiomes Product Type_x000D_
Table 9. List of India Tier 1 Microbiomes Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Microbiomes Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Microbiomes Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Microbiomes Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Microbiomes Sales in India (K Units), 2015-2020_x000D_
Table 14. By Type - Microbiomes Sales in India (K Units), 2021-2026_x000D_
Table 15. By Application - Microbiomes Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Microbiomes Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Microbiomes Sales in India, (K Units), 2015-2020_x000D_
Table 18. By Application - Microbiomes Sales in India, (K Units), 2021-2026_x000D_
Table 19. 4D Pharma Corporate Summary_x000D_
Table 20. 4D Pharma Microbiomes Product Offerings_x000D_
Table 21. 4D Pharma Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 22. Enterome BioScience Corporate Summary_x000D_
Table 23. Enterome BioScience Microbiomes Product Offerings_x000D_
Table 24. Enterome BioScience Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 25. Evelo Biosciences Corporate Summary_x000D_
Table 26. Evelo Biosciences Microbiomes Product Offerings_x000D_
Table 27. Evelo Biosciences Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 28. Ferring Corporate Summary_x000D_
Table 29. Ferring Microbiomes Product Offerings_x000D_
Table 30. Ferring Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 31. Osel Corporate Summary_x000D_
Table 32. Osel Microbiomes Product Offerings_x000D_
Table 33. Osel Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 34. Second Genome Corporate Summary_x000D_
Table 35. Second Genome Microbiomes Product Offerings_x000D_
Table 36. Second Genome Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 37. Seres Therapeutics Corporate Summary_x000D_
Table 38. Seres Therapeutics Microbiomes Product Offerings_x000D_
Table 39. Seres Therapeutics Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 40. Synlogic Corporate Summary_x000D_
Table 41. Synlogic Microbiomes Product Offerings_x000D_
Table 42. Synlogic Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 43. Synthetic Biologics and Vedanta Biosciences Corporate Summary_x000D_
Table 44. Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offerings_x000D_
Table 45. Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 46. Vedanta Corporate Summary_x000D_
Table 47. Vedanta Microbiomes Product Offerings_x000D_
Table 48. Vedanta Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 49. Rebiotix Corporate Summary_x000D_
Table 50. Rebiotix Microbiomes Product Offerings_x000D_
Table 51. Rebiotix Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 52. ActoGeniX Corporate Summary_x000D_
Table 53. ActoGeniX Microbiomes Product Offerings_x000D_
Table 54. ActoGeniX Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 55. Enterologics Corporate Summary_x000D_
Table 56. Enterologics Microbiomes Product Offerings_x000D_
Table 57. Enterologics Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 58. Metabogen Corporate Summary_x000D_
Table 59. Metabogen Microbiomes Product Offerings_x000D_
Table 60. Metabogen Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 61. Metabiomics Corporate Summary_x000D_
Table 62. Metabiomics Microbiomes Product Offerings_x000D_
Table 63. Metabiomics Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 64. Ritter Pharmaceuticals Corporate Summary_x000D_
Table 65. Ritter Pharmaceuticals Microbiomes Product Offerings_x000D_
Table 66. Ritter Pharmaceuticals Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 67. AvidBiotics Corporate Summary_x000D_
Table 68. AvidBiotics Microbiomes Product Offerings_x000D_
Table 69. AvidBiotics Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 70. Symberix Corporate Summary_x000D_
Table 71. Symberix Microbiomes Product Offerings_x000D_
Table 72. Symberix Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 73. Miomics Corporate Summary_x000D_
Table 74. Miomics Microbiomes Product Offerings_x000D_
Table 75. Miomics Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 76. Symbiotix Biotherapies Corporate Summary_x000D_
Table 77. Symbiotix Biotherapies Microbiomes Product Offerings_x000D_
Table 78. Symbiotix Biotherapies Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 79. MicroBiome Therapeutics LLC Corporate Summary_x000D_
Table 80. MicroBiome Therapeutics LLC Microbiomes Product Offerings_x000D_
Table 81. MicroBiome Therapeutics LLC Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
Table 82. SciBac Inc Corporate Summary_x000D_
Table 83. SciBac Inc Microbiomes Product Offerings_x000D_
Table 84. SciBac Inc Microbiomes Revenue (US$, Mn), (2015-2020)_x000D_
List of Figures_x000D_
Figure 1. Microbiomes Segment by Type_x000D_
Figure 2. Microbiomes Segment by Application_x000D_
Figure 3. India Microbiomes Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Microbiomes Market Size in India, (US$, Mn): 2020 VS 2026_x000D_
Figure 6. India Microbiomes Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. The Top 3 and 5 Players Market Share by Microbiomes Revenue in 2019_x000D_
Figure 8. By Type - India Microbiomes Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 9. By Type - India Microbiomes Market Share, 2015-2026_x000D_
Figure 10. By Application - Microbiomes Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 11. By Application - India Microbiomes Market Share, 2015-2026_x000D_
Figure 12. PEST Analysis for India Microbiomes Market in 2020_x000D_
Figure 13. Microbiomes Market Opportunities & Trends in India_x000D_
Figure 14. Microbiomes Market Drivers in India_x000D_

Kindly Fill The Form Below

Report Title: Microbiomes Market in India - Industry Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW